Similar articles

• Immunotherapy of cancer in man: current status and prospectus.

  Carter SK. Carter SK. Ann N Y Acad Sci. 1976;277(00):722-40. doi: 10.1111/j.1749-6632.1976.tb41745.x. Ann N Y Acad Sci. 1976. PMID: 793477 Review. No abstract available.
• Critical review of previously reported clinical trials of cancer immunotherapy with nonspecific immunostimulants.

  Mastrangelo MJ, Berd D, Bellet RE. Mastrangelo MJ, et al. Ann N Y Acad Sci. 1976;277(00):94-123. doi: 10.1111/j.1749-6632.1976.tb41693.x. Ann N Y Acad Sci. 1976. PMID: 793490 Review. No abstract available.
• Immunotherapy for malignant disease.

  [No authors listed] [No authors listed] Med Lett Drugs Ther. 1976 Sep 24;18(20):83-4. Med Lett Drugs Ther. 1976. PMID: 1066519 No abstract available.
• Immunotherapy in the treatment of acute leukaemia.

  Whittaker JA. Whittaker JA. Br J Haematol. 1980 Jun;45(2):187-93. doi: 10.1111/j.1365-2141.1980.tb07137.x. Br J Haematol. 1980. PMID: 6934004 No abstract available.
• Immunotherapy of human acute leukaemia.

  Alexander P, Powles R. Alexander P, et al. Clin Haematol. 1978 Jun;7(2):275-94. doi: 10.1016/s0308-2261(78)80006-x. Clin Haematol. 1978. PMID: 28191 Review.